well
establish
type
ifn
ifn
restrict
acut
infect
clinic
trial
treat
human
patient
recombin
ifn
suppress
viral
replic
absenc
antiretrovir
therapi
art
howev
approach
fail
treatment
studi
subject
becam
refractori
ifn
treatment
viral
load
return
previou
level
ifn
import
establish
earli
control
vivo
siv
rhesu
macaqu
chronic
ifn
signal
correl
chronic
immun
activ
immun
exhaust
elev
gene
isg
express
poor
control
two
recent
publish
studi
shown
human
mous
model
infect
experiment
blockad
ifn
signal
result
restor
immun
function
rescu
cell
function
includ
chronic
lymphocyt
choriomening
viru
lcmv
infect
blockad
receptor
ifnar
also
signific
studi
highlight
import
ifn
regul
context
infect
specif
viral
infect
gener
howev
littl
known
induc
ifn
ifn
unabl
control
infect
vivo
signal
ifnar
result
phosphoryl
activ
stat
protein
includ
consequ
phosphoryl
induc
express
hundr
protein
product
isg
target
host
viral
machineri
mean
restrict
viral
replic
howev
small
subset
isg
express
neg
feedback
mechan
turn
ifn
signal
resolut
immun
respons
occur
one
import
neg
regul
proteinas
deisgyl
enzym
specif
remov
posttransl
modif
target
ifn
respons
mani
newli
synthes
protein
varieti
effect
depend
target
target
ifn
regulatori
factor
protect
proteasom
also
shown
viral
protein
includ
gag
durfe
propos
infect
small
subset
viral
structur
protein
isgyl
disrupt
repeat
structur
found
viral
capsid
influenza
b
evolv
mechan
directli
neutral
coronavirus
proteas
deisgylas
activ
strategi
overcom
indic
import
antivir
respons
addit
enzymat
activ
neg
regul
ifn
recruit
type
ifn
receptor
subunit
bind
prevent
phosphoryl
block
interact
express
also
play
role
limit
apoptosi
also
shown
regul
suscept
certain
cancer
cell
macrophag
play
import
role
reservoir
contribut
directli
art
era
seen
chronic
diseas
character
chronic
immun
activ
chronic
inflamm
higher
risk
morbid
mortal
macrophag
play
import
role
process
act
mediat
recent
report
replic
macrophag
requir
activ
protein
usual
associ
antivir
role
postintegr
express
mrna
long
termin
repeat
ltr
promot
paradox
mechan
usurp
antivir
pathway
mean
drive
replic
suggest
complex
interplay
ultim
determin
effici
replic
macrophag
gener
role
macrophag
life
cycl
import
elimin
persist
infect
macrophag
addit
latent
infect
cell
necessari
steril
cure
achiev
thu
critic
understand
dynam
regul
replic
macrophag
understand
subvert
innat
immun
respons
includ
potent
antivir
ifn
respons
data
show
express
induc
human
macrophag
goal
studi
determin
role
infectionrepl
determin
effect
benefit
hypothes
suppress
antivir
pathway
would
normal
restrict
perturb
would
restor
enhanc
pathway
lead
better
control
viru
test
util
novel
cluster
regularli
interspac
short
palindrom
repeat
crispr
protein
knockout
induc
pluripot
stem
cell
ipsc
macrophag
model
data
show
experiment
deplet
human
macrophag
model
restrict
replic
due
enhanc
cellular
antivir
respons
increas
sensit
effect
ifn
thu
benefit
replic
strike
balanc
weak
ifn
signal
requir
viral
replic
strong
ifn
signal
would
halt
viral
replic
pbmc
prepar
leukopak
obtain
healthi
donor
lifesouth
commun
blood
center
gainesvil
fl
approv
institut
review
board
univers
florida
pbmc
isol
centrifug
lymphocyt
separ
medium
mp
biomed
santa
ana
ca
medium
monocyt
isol
posit
select
ls
column
miltenyi
biotec
bergisch
gladbach
germani
human
microbead
miltenyi
biotec
freshli
isol
monocyt
differenti
macrophag
mdm
medium
dmem
gl
glucos
corn
corn
ny
human
serum
research
triangl
park
nc
mm
corn
iu
corn
supplement
ngml
day
differenti
medium
replenish
without
cell
rest
overnight
use
experi
cell
atcc
manassa
va
cultur
medium
contain
rpmi
mm
corn
fb
st
loui
mo
iu
corn
mm
hepe
corn
gl
mm
sodium
pyruv
corn
mm
gibco
gaithersburg
md
cell
differenti
adher
macrophag
ad
nm
pma
day
pma
remov
cell
wash
pb
rest
overnight
medium
cell
clontech
mountain
view
ca
cultur
maintain
medium
dmem
corn
fb
iu
corn
mm
corn
sodium
bicarbon
corn
cell
obtain
nih
aid
reagent
program
divis
aid
niaid
nih
dr
john
c
kapp
dr
xiaoyun
wu
tranzym
cultur
maintain
medium
cell
obtain
nih
aid
reagent
program
divis
aid
niaid
nih
dr
thoma
cultur
maintain
rpmi
mm
corn
fb
iu
corn
mm
hepe
corn
purchas
peprotech
rocki
hill
nj
neutral
antibodi
purchas
pbl
assay
scienc
piscataway
nj
purifi
mous
isotyp
control
antibodi
purchas
biolegend
san
diego
ca
monoclon
antibodi
polyclon
antibodi
igg
igg
secondari
antibodi
purchas
cell
signal
technolog
danver
antibodi
purchas
abcam
cambridg
isotyp
control
flow
antibodi
purchas
ebiosci
san
diego
ca
hivhsa
previous
describ
kind
gift
dr
michel
j
pnl
hivad
obtain
nih
aid
research
refer
reagent
program
divis
aid
niaid
nih
pnl
fisher
cell
cultur
flask
transfect
use
red
transfect
reagent
lipocalyx
hall
germani
pnl
use
fugen
hd
transfect
reagent
promega
madison
wi
transfect
reagent
remov
h
medium
replenish
h
infecti
supernat
collect
clarifi
filter
pore
size
whatman
pe
membran
fisher
scientif
suwane
ga
fb
ad
viru
concentr
store
h
aliquot
frozen
viru
quickli
thaw
water
bath
viru
titer
cell
h
luciferas
assay
perform
titer
determin
express
medium
remov
aspir
room
temperatur
luciferas
assay
system
promega
ad
cell
min
cell
lyse
lysat
transfer
black
costar
eiaria
polystyren
half
area
plate
corn
luminesc
measur
reader
perkinelm
waltham
measur
supernat
human
duoset
elisa
kit
accord
manufactur
instruct
r
system
minneapoli
mn
measur
supernat
lyse
triton
pb
elisa
kit
accord
manufactur
instruct
sino
biolog
beij
china
macrophag
mdm
infect
hivad
day
total
rna
collect
rneasi
mini
kit
qiagen
valencia
ca
gene
express
assess
human
exon
st
array
affymetrix
santa
clara
ca
interdisciplinari
center
biotechnolog
research
univers
florida
analysi
perform
partek
genom
suit
v
partek
inc
st
loui
mo
cel
file
import
gc
correct
intens
data
transform
log
base
exon
summar
gene
use
median
method
anova
contrast
perform
determin
fold
chang
control
treatment
group
microarray
data
deposit
gene
express
omnibu
access
cell
wash
pb
lyse
cell
lysi
buffer
cell
signal
technolog
proteas
inhibitor
cocktail
mm
pmsf
protein
separ
size
precast
gel
hercul
ca
electroblot
onto
mini
pvdf
membran
use
transfer
system
accord
manufactur
instruct
membran
block
nonfat
milk
tbst
super
west
dura
extend
durat
substrat
kit
use
chemiluminesc
detect
secondari
antibodi
blot
expos
film
thermo
scientif
waltham
blot
strip
incub
plu
western
blot
strip
buffer
thermo
scientif
human
gipz
lentivir
shrna
gene
set
shrna
purchas
ge
dharmacon
lafayett
co
shrna
clone
screen
hek
cell
clone
determin
effici
knockdown
data
shown
use
subsequ
experi
gipz
plasmid
dna
cotransfect
packag
cell
cultur
medium
tet
system
approv
fb
use
htx
packag
system
clontech
xfect
transfect
reagent
clontech
accord
manufactur
instruct
transfect
reagent
remov
h
posttransfect
h
supernat
contain
pseudotyp
lentiviru
harvest
clarifi
centrifug
x
g
h
supernat
decant
pellet
resuspend
medium
cell
transduc
transdux
system
bioscienc
mountain
view
ca
spinocul
hour
x
g
room
temperatur
puromycin
use
select
transduc
cell
h
posttransduct
pool
control
sirna
sirna
smartpool
purchas
ge
dharmacon
sirna
transfect
cell
blue
transfect
reagent
lipocalyx
concentr
nm
accord
manufactur
instruct
total
rna
isol
rneasi
plu
mini
kit
qiagen
cdna
synthesi
carri
cdna
revers
transcript
kit
appli
biosystem
foster
citi
ca
accord
manufactur
instruct
predesign
qpcr
assay
purchas
integr
dna
technolog
coralvil
ia
reaction
carri
taqman
univers
pcr
master
mix
thermo
fisher
scientif
accord
manufactur
instruct
reaction
perform
pcr
system
appli
biosystem
donor
hematopoiet
progenitor
cell
isol
peripher
blood
util
easysep
complet
kit
human
whole
blood
cell
stem
cell
technolog
vancouv
canada
isol
cell
expand
stemspan
sfem
ii
medium
plu
stemspan
expans
supplement
week
follow
expans
cell
infect
sendai
viral
vector
sevdp
kosm
encod
reprogram
factor
infect
carri
h
moi
cell
reprogram
dish
use
reprotesr
stem
cell
technolog
follow
manufactur
instruct
approxim
week
infect
ipsc
coloni
manual
isol
gener
ipsc
clone
ipsc
clone
maintain
expand
plate
stem
cell
technolog
ipsc
character
assess
morpholog
express
stem
cell
marker
flow
cytometri
analysi
karyotyp
pluripot
confirm
differenti
cell
ectoderm
endoderm
mesoderm
lineag
use
stemdiff
trilineag
differenti
kit
stem
cell
technolog
flow
cytometri
use
examin
undifferenti
ipsc
stain
antibodi
biolegend
trilineag
differenti
ipsc
ectoderm
assess
fluor
bd
bioscienc
san
jose
ca
endoderm
assess
fluor
bd
bioscienc
mesoderm
assess
r
system
stem
cell
technolog
differenti
carri
previous
slight
modif
briefli
ipsc
passag
spars
plate
cultur
day
daili
medium
chang
coloni
approxim
mm
diamet
next
embryoid
bodi
eb
form
gentli
lift
coloni
use
cell
lifter
coloni
gentli
transfer
ml
conic
tube
use
ml
serolog
pipett
coloni
allow
graviti
settl
approxim
min
supernat
aspir
cell
gentli
resuspend
supplement
rock
inhibitor
transfer
attach
surfac
plate
corn
contain
ml
medium
per
well
eb
allow
form
day
partial
medium
chang
h
day
eb
collect
wash
resuspend
supplement
gibco
gibco
transfer
adher
cell
plate
ipsc
transfect
use
human
stem
cell
nucleofector
kit
lonza
basal
switzerland
follow
manufactur
recommend
plasmid
plasmid
encod
pyogen
plasmid
contain
grna
sequenc
gcaaatctgtcagtccatcc
donor
plasmid
homolog
arm
flank
crispr
site
exon
deliv
gfp
puromycin
resist
gene
cassett
briefli
equal
amount
plasmid
total
nucleofect
cell
use
nucleofector
ii
amaxa
biosystem
cologn
germani
program
cell
dish
allow
recov
day
daili
medium
chang
gfp
fluoresc
observ
h
day
cell
maintain
puromycin
select
day
ten
clone
manual
isol
expand
genom
dna
isol
use
dneasi
blood
tissu
kit
qiagen
screen
primer
sequenc
screen
crispr
modif
supplement
tabl
invitrogen
carlsbad
ca
ad
cell
concentr
live
reagent
molecular
probe
eugen
also
ad
well
incub
min
cell
wash
prewarm
pb
fix
paraformaldehyd
phrodo
red
bioparticl
resuspend
live
cell
imag
solut
gibco
sonic
min
water
bath
sonic
resuspend
phrodo
escherichia
coli
staphylococcu
aureu
ad
final
concentr
live
cell
imag
solut
macrophag
incub
h
allow
uptak
acidif
phagosom
live
reagent
molecular
probe
ad
imag
fluoresc
imag
obtain
fl
cell
imag
system
invitrogen
mdm
imac
wash
pb
fix
cold
paraformaldehyd
min
cell
wash
pb
permeabil
triton
cell
wash
pb
stain
either
reagent
molecular
probe
min
follow
wash
pb
cell
imag
fl
cell
imag
system
invitrogen
fc
receptor
block
fc
block
miltenyi
stain
antibodi
pb
human
serum
intracellular
stain
cell
fix
permeabil
bd
kit
bd
bioscienc
sampl
analyz
bd
cytomet
bd
bioscienc
integr
assay
detect
integr
provir
dna
adapt
method
previous
briefli
genom
dna
isol
dneasi
blood
tissu
kit
qiagen
preamplif
step
nm
primer
perform
ng
genom
dna
amplitaq
master
mix
gc
enhanc
appli
biosystem
incub
thermal
cycler
min
follow
cycl
sec
final
extens
step
min
second
round
pcr
perform
product
preamplif
step
nm
lambda
primer
nm
taqman
probe
univers
master
mix
appli
biosystem
thermal
cycler
condit
recommend
manufactur
master
mix
parallel
sampl
standard
curv
also
underw
preamplif
second
amplif
step
standard
curv
prepar
cell
cell
line
exactli
integr
provir
genom
standard
curv
prepar
make
dilut
ng
genom
dna
cell
carrier
dna
uninfect
pbmc
ad
total
genom
dna
standard
ng
primer
sequenc
list
supplement
tabl
use
estim
pg
genom
dna
per
cell
number
copi
integr
provir
genom
per
cell
calcul
standard
curv
demonstr
previous
vitro
ifn
restrict
confirm
previou
find
pretreat
cell
differ
dose
h
infect
cell
previous
report
ifn
restrict
replic
manner
fig
also
test
mdm
found
replic
potent
restrict
manner
fig
fgml
fgml
sinc
restrict
ifn
vitro
want
determin
induc
ifn
respons
mdm
test
mdm
infect
day
gene
express
analyz
microarray
fig
observ
gene
least
tabl
report
interferom
databas
fig
howev
respons
strong
enough
inhibit
replic
degre
addit
exogen
ifn
fig
interest
ifn
respons
attenu
allow
replic
occur
despit
induct
isg
interestingli
induc
express
tabl
neg
regul
ifn
western
blot
analysi
confirm
protein
level
differ
strain
fig
unknown
induc
express
human
macrophag
sinc
isg
first
pretreat
mdm
neutral
antibodi
infect
cell
see
still
induc
absenc
ifn
signal
result
show
induc
absenc
ifn
signal
fig
provid
evid
induc
ifn
respons
macrophag
autocrin
effect
surprisingli
replic
inhibit
enhanc
absenc
ifn
signal
measur
elisa
supernat
fig
find
agre
previou
work
demonstr
import
stat
signal
replic
data
demonstr
must
strike
balanc
ifn
signal
need
produc
transcript
factor
much
ifn
signal
allow
cell
mount
effect
antivir
respons
given
attenu
ifn
respons
hypothes
induct
allow
achiev
balanc
need
provid
necessari
stat
signal
without
strong
antivir
respons
part
normal
neg
feedback
respons
regul
ifn
signal
ifnar
signal
absenc
signal
pathway
enhanc
increas
level
phosphoryl
use
sirna
knockdown
express
mdm
treat
hour
found
increas
level
phosphoryl
fig
increas
signal
result
enhanc
express
isg
test
mdm
transfect
sirna
treat
h
gene
express
isg
analyz
panel
look
gene
increas
express
knock
compar
control
fig
express
also
measur
confirm
knockdown
transcript
next
want
determin
express
necessari
replic
although
transfect
mdm
sirna
allow
effici
knockdown
fig
also
made
cell
refractori
infect
even
nontarget
control
sirna
data
shown
instead
util
shrna
knockdown
cell
line
cell
suspens
cell
differenti
adher
cell
pma
treatment
model
system
studi
infect
gener
cell
line
constitut
express
nontarget
control
shrna
supplement
fig
pma
differenti
cell
express
control
shrna
infect
found
replic
significantli
restrict
cell
knockdown
significantli
less
detect
supernat
protein
lysat
knockdown
cell
compar
control
fig
cell
mdm
knockdown
provid
use
model
investig
effect
defici
ifn
signal
may
best
model
cell
transform
cell
abnorm
hand
remain
differenti
adher
cultur
day
data
shown
could
achiev
effici
knockdown
mdm
transfect
cell
becam
refractori
infect
even
nontarget
control
sirna
use
overcom
obstacl
sought
use
macrophag
model
macrophag
previous
shown
suitabl
model
studi
first
gener
ipsc
cell
isol
peripher
blood
healthi
adult
human
donor
supplement
fig
cell
expand
vitro
transduc
nonintegr
sendai
viral
vector
sevdp
kosm
encod
reprogram
differenti
util
eb
method
eb
form
cultur
presenc
gener
monocyt
cultur
alon
produc
mdm
ipsc
imac
imac
similar
morpholog
mdm
supplement
fig
confirm
imac
also
function
like
mdm
imac
treat
ovalbumin
fluoresc
label
intramolecular
quencher
protein
phagocytos
process
acid
proteas
digest
free
fluorophor
quencher
allow
fluoresc
imac
fed
posit
bodipi
fl
dye
indic
ovalbumin
process
acid
proteas
supplement
fig
determin
imac
phagocytos
whole
bacteria
process
acidifi
phagosom
heat
kill
e
coli
aureu
label
ph
sensit
dye
fed
imac
h
imac
rfp
posit
indic
phagocytos
bacteria
phagosom
acidifi
supplement
fig
test
effect
defici
imac
util
gene
edit
knockout
ipsc
differenti
myeloid
lineag
advantag
knock
ipsc
knockout
achiev
ipsc
line
continu
sourc
new
eb
make
imac
knockout
ipsc
transfect
plasmid
deliv
target
rna
sgrna
donor
plasmid
homolog
arm
region
sgrna
target
exon
fig
donor
dna
contain
gfp
puromycin
resist
gene
allow
select
success
modifi
cell
puromycin
resist
clone
screen
pcr
western
blot
success
knockout
fig
two
knockout
clone
gfp
clone
clone
obtain
use
subsequ
experi
lack
gfp
express
knockout
clone
like
due
silenc
promot
phenomenon
observ
portion
modifi
ipsc
line
determin
knockout
imac
similar
phenotyp
knockdown
mdm
imac
treat
level
phosphoryl
measur
western
blot
imac
increas
sustain
phosphoryl
phosphoryl
fig
sinc
imac
also
increas
signal
want
determin
imac
also
enhanc
isg
express
treatment
inde
treatment
h
imac
increas
express
isg
compar
suffici
cell
fig
find
consist
result
sirna
knockdown
mdm
next
determin
imac
support
replic
previous
induc
imac
inde
imac
support
replic
induc
cell
fig
sinc
induc
imac
similar
manner
mdm
conclud
imac
better
model
studi
knockoutknockdown
cell
next
want
determin
knockout
influenc
replic
knockout
result
enhanc
respons
ifn
stimul
macrophag
fig
therefor
hypothes
replic
would
restrict
imac
due
enhanc
ifn
signal
respons
infect
imac
infect
signific
reduct
supernat
intracellular
determin
elisa
western
blot
imac
day
postinfect
fig
also
want
determin
restrict
replic
due
fewer
cell
becom
infect
first
round
infect
due
decreas
spread
test
imac
infect
treat
darunavir
proteas
inhibitor
prevent
subsequ
round
infect
h
genom
dna
collect
qpcr
assay
develop
measur
integr
provir
genom
show
averag
genom
per
cell
imac
averag
integr
genom
per
cell
imac
treat
darunavir
h
postinfect
suggest
decreas
viral
replic
seen
time
day
due
restrict
product
spread
viru
due
decreas
inhibit
entri
cell
report
defici
restrict
replic
human
macrophag
use
ipsc
model
restrict
replic
due
enhanc
ifn
respons
lack
feedback
inhibit
jakstat
pathway
result
increas
express
isg
antivir
effect
previou
work
done
group
shown
necessari
effici
replic
block
phosphoryl
either
molecul
result
signific
reduct
viral
howev
current
studi
show
increas
amount
phosphoryl
also
result
signific
reduct
viral
replic
thu
propos
act
tune
mechan
prevent
robust
ifn
respons
would
restrict
viral
replic
fig
previou
work
shown
mice
exhibit
protect
intracerebr
infect
lcmv
mice
also
increas
abil
restrict
salmonella
typhimurium
replic
increas
surviv
lethal
challeng
typhimurium
basi
antibacteri
protect
defici
attribut
hypersensit
lp
consequ
overact
ifn
mechanist
studi
show
defici
result
increas
isgyl
protein
increas
phosphoryl
level
respons
lp
treatment
viral
infect
base
properti
sought
determin
human
regul
replic
differ
biochem
regul
human
compar
mice
provid
rational
studi
defici
human
cell
exampl
although
human
mous
share
gener
function
human
isgyl
promot
stabil
protein
thu
knockout
cell
similarli
enhanc
isg
respons
human
due
fact
defici
infant
born
natur
occur
defici
experi
rubella
cytomegaloviru
herp
simplex
syndrom
result
aberr
ifn
respons
absenc
congenit
lead
us
believ
overal
hyperact
ifn
phenotyp
observ
mice
would
recapitul
human
similar
mous
studi
current
work
show
defici
human
macrophag
also
enhanc
level
phosphoryl
phosphoryl
treatment
expect
enhanc
signal
ifnar
would
increas
express
isg
mani
known
properti
inde
found
defici
cell
express
isg
enhanc
treatment
consist
work
done
murin
macrophag
treat
demonstr
increas
gene
involv
antigen
process
present
cytokin
chemokin
well
gene
involv
respons
viral
mice
vivo
protect
viral
infect
mediat
mechan
known
enforc
viral
replic
wherebi
margin
zone
macrophag
becom
resist
effect
shield
macrophag
full
antivir
effect
ifn
cell
express
viral
protein
util
protein
prime
adapt
immun
seem
exploit
properti
mean
tune
antivir
respons
favor
replic
isgyl
protein
previous
shown
import
restrict
mani
differ
virus
includ
vsv
hcv
chikungunya
influenza
influenza
b
lcmv
sindbi
previou
studi
shown
isgyl
import
restrict
hela
cell
howev
unawar
studi
show
relev
isgyl
primari
cell
cell
human
mdm
human
cell
move
forward
key
area
focu
determin
function
domain
requir
replic
dissect
rel
role
deisgyl
versu
ifnar
block
process
demonstr
defici
cell
first
round
infect
unaffect
viru
enter
target
cell
revers
transcrib
cdna
integr
provir
genom
host
chromosom
like
result
first
round
infect
de
novo
ifn
synthesi
lag
rapid
provir
integr
process
follow
initi
infect
prolong
spread
infect
cultur
cell
like
reduc
net
provir
integr
initi
ifn
respons
amplifi
cell
sens
viral
nucleic
acid
infect
cell
ifn
produc
secret
surround
environ
inde
see
protein
express
perturb
ifn
signal
block
autocrineparacrin
signal
feed
forward
antivir
mechan
ifn
express
isg
establish
nonpermiss
environ
viral
replic
express
hundr
isg
protein
product
find
attenu
antivir
mechan
context
infect
net
benefici
effect
viru
overrid
key
antivir
signal
proxim
event
ifn
signal
phosphoryl
jakstat
protein
augment
absenc
conclud
effect
fundament
phenotyp
restrict
replic
cell
uninfect
cell
receiv
paracrin
signal
ifn
isg
demonstr
defici
cell
increas
express
treatment
exogen
mani
gene
previous
shown
restrict
ifit
famili
protein
shown
restrict
shut
machineri
use
viru
translat
viral
ifitm
famili
member
shown
inhibit
interf
viral
fusion
could
potenti
result
fewer
cell
infect
anoth
factor
shown
restrict
effect
isg
may
simpli
enhanc
absenc
role
vivo
may
help
recruit
cell
interact
infect
macrophag
ifn
secret
induc
low
level
detect
microarray
day
product
infect
macrophag
clearli
rel
small
amount
ifn
produc
earli
infect
meaning
effect
viru
replic
ifnar
block
antibodi
use
infect
reduc
rather
enhanc
demonstr
low
level
ifn
benefit
viru
time
induc
includ
demonstr
low
level
ifn
produc
respons
induct
well
transcript
respons
provid
exogen
abl
demonstr
lack
make
cell
sensit
effect
ifn
strategi
use
transcript
ltr
promot
util
transcript
factor
nfat
would
normal
present
cell
detect
viral
infect
initi
antivir
respons
util
transcript
machineri
abl
hijack
normal
immun
process
improv
fit
howev
vitro
experi
long
demonstr
inflammatori
activ
like
lp
ifn
potent
restrict
replic
thu
physiolog
state
support
replic
window
low
level
immun
activ
due
least
part
balanc
posit
neg
regul
antivir
immun
fig
infect
cell
eventu
becom
refractori
ifn
signal
due
induct
neg
regul
neg
regul
also
induc
ifn
includ
focus
studi
due
addit
function
deisgyl
enzym
appear
gene
express
profil
experi
follow
infect
cell
model
previous
use
studi
diseas
varieti
differ
cell
type
includ
vascular
smooth
muscl
cell
cardiomyocyt
macrophag
previous
shown
use
model
confirm
find
current
studi
imac
model
support
robust
replic
show
similar
induct
respons
infect
occur
mdm
use
cell
sever
advantag
convent
cell
model
first
ipsc
technolog
use
deriv
cell
may
obtain
larg
number
live
human
donor
second
ipsc
grown
indefinit
cultur
allow
iter
mechanist
experi
thu
reduc
variabl
third
cell
genet
modifi
use
gene
edit
technolog
allow
renew
sourc
edit
cell
knockout
unedit
ipsc
deriv
donor
complement
method
sirna
transfect
primari
cell
mdm
conclus
shown
novel
macrophag
model
requir
replic
vitro
propos
durabl
enhanc
ifn
signal
restrict
replic
vivo
certain
element
isg
respons
limit
neg
regul
serv
import
cellular
function
limit
magnitud
initi
respons
help
resolv
respons
follow
earli
signal
event
show
capit
biolog
effect
neg
regul
mean
tune
ifn
respons
increas
viral
fit
mani
studi
focus
antivir
effect
isg
understand
host
cell
regul
antivir
pathway
unveil
complet
biolog
mechan
mani
infect
hereditari
diseas
easili
model
rodent
new
platform
requir
answer
key
question
host
geneprotein
includ
neg
regul
signal
demonstr
cell
model
pair
genom
edit
technolog
power
tool
studi
infect
also
use
studi
infecti
diseas
model
autoimmun
gener
biolog
problem
lack
high
qualiti
convent
cell
line
model
